Do Gleason patterns 3 and 4 prostate cancer represent separate disease states?

Area of Science:

• Prostate cancer research
• Uropathology
• Oncology

Background:

• The Gleason scoring system is foundational for prostate cancer assessment and treatment studies.
• The 2005 International Society of Urological Pathology (ISUP) update provides insights into prostate cancer biology correlating with histopathology.
• Understanding distinct developmental pathways within the Gleason score is crucial for characterizing prostate cancer indolence or aggressiveness.

Purpose of the Study:

• To present a conceptual framework for distinct but interrelated developmental pathways in prostate cancer based on the Gleason score.
• To aid in characterizing prostate cancer as indolent or aggressive.
• To assist in treatment decision-making and interpreting disease course and outcomes.

Main Methods:

• A comprehensive review of clinical, pathological, and biological literature was conducted.
• The biological behavior of prostate cancer was compared to other solid neoplasms.
• A schema for characterizing disease pathogenesis was developed.

Main Results:

• The Gleason score is vital for predicting prostate cancer behavior and treatment outcomes.
• The proportion of Gleason pattern 4 is a critical predictor of biochemical recurrence and mortality.
• Increasing Gleason 4 components correlate with higher risks, suggesting earlier disease detection or more aggressive tumor evolution.

Conclusions:

• Gleason 4 (and 5) cancers represent distinct diatheses from Gleason 3 cancers due to progressive mortality risks.
• This distinction enhances understanding of intrinsic prognosis.
• It guides the translation of molecular and histological findings to precise treatment selection.